(INNF)
CARLUMAB(INNS)
CARLUMAB(INND)
KARLUMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CCL2 (CHEMOKINE (C-C MOTIF) LIGAND 2, C-C MOTIF CHEMOKINE 2, MONOCYTE CHEMOATTRACTANT PROTEIN-1, MCP-1, MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR, MCAF, SMALL INDUCIBLE CYTOKINE A2, SCYA2, HC11)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) [HOMO SAPIENS VH (IGHV1-69*01 (99.00%) -(IGHD)-IGHJ4*01 [8.8.12] (1-119) -IGHG1*01 (120-449)), (222-216')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-216') [HOMO SAPIENS V-KAPPA (IGKV3-11*01 (94.50%) -IGKJ1*01) [7.3.10] (1'-109') - IGKC*01 (110'-216')]; (228-228'':231-231'')-BISDISULFIDE DIMER, RECOMMENDED INN: LIST 66(WHO)
CARLUMABUM(INN)